Exact Mass: 200.12824675599998
Exact Mass Matches: 200.12824675599998
Found 119 metabolites which its exact mass value is equals to given mass value 200.12824675599998,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Medetomidine
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Dexmedetomidine ((+)-Medetomidine) is a potent, selective and orally active agonist of α2-adrenoceptor, with a Ki of 1.08 nM. Dexmedetomidine shows 1620-fold selectivity against α1-adrenoceptor. Dexmedetomidine exhibits anxiolysis, sedation, and modest analgesia effects[1][2][3]. Medetomidine is an orally active α2-adrenoceptor agonist (Ki: 1.08 nM). Medetomidine has sedative and analgesic effects. Medetomidine can cause peripheral vasoconstriction through the activation of α2 adrenoceptors on blood vessels[1][2][3][4].
tetrahydrozoline
R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AB - Sympathomimetics, combinations excl. corticosteroids R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AA - Sympathomimetics, plain S - Sensory organs > S01 - Ophthalmologicals > S01G - Decongestants and antiallergics > S01GA - Sympathomimetics used as decongestants D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D019999 - Pharmaceutical Solutions > D009883 - Ophthalmic Solutions D019141 - Respiratory System Agents > D014663 - Nasal Decongestants D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents Tetrahydrozoline (Tetryzoline), a derivative of imidazoline, is an α-adrenergic agonist that causes vasoconstriction. Tetrahydrozoline is widely used for the research of nasal congestion and conjunctival congestion[1][2].
Dexmedetomidine
Dexmedetomidine is only found in individuals that have used or taken this drug. It is an agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine. [PubChem]Dexmedetomidine is a specific and selective alpha-2 adrenoceptor agonist. By binding to the presynaptic alpha-2 adrenoceptors, it inhibits the release if norepinephrine, therefore, terminate the propagation of pain signals. Activation of the postsynaptic alpha-2 adrenoceptors inhibits the sympathetic activity decreases blood pressure and heart rate. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives D002491 - Central Nervous System Agents > D000700 - Analgesics Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Dexmedetomidine ((+)-Medetomidine) is a potent, selective and orally active agonist of α2-adrenoceptor, with a Ki of 1.08 nM. Dexmedetomidine shows 1620-fold selectivity against α1-adrenoceptor. Dexmedetomidine exhibits anxiolysis, sedation, and modest analgesia effects[1][2][3]. Medetomidine is an orally active α2-adrenoceptor agonist (Ki: 1.08 nM). Medetomidine has sedative and analgesic effects. Medetomidine can cause peripheral vasoconstriction through the activation of α2 adrenoceptors on blood vessels[1][2][3][4].
2-(2-Methylpropoxy)naphthalene
2-(2-Methylpropoxy)naphthalene is a flavouring ingredien Flavouring ingredient
Ecgoninium Methyl Ester(1+)
Ecgoninium Methyl Ester(1+) is also known as Ecgonine methyl ester or Ecgonine methyl ester, (1R-(endo,endo))-isomer. Ecgoninium Methyl Ester(1+) is considered to be slightly soluble (in water) and relatively neutral
levomedetomidine
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics Medetomidine is an orally active α2-adrenoceptor agonist (Ki: 1.08 nM). Medetomidine has sedative and analgesic effects. Medetomidine can cause peripheral vasoconstriction through the activation of α2 adrenoceptors on blood vessels[1][2][3][4].
1-Pyrrolidinyloxy, 3-(methoxycarbonyl)-2,2,5,5-tetramethyl-
Dehydrochamecynenal
cis-Tetradecen-(5)-triin-(8.10.12)-ol-(1)|tetradec-5c-ene-8,10,12-triyn-1-ol
(E,E,E)-form-4,6,12-Tetradecatriene-8,10-diyn-1-ol,|4,6,12-Tetradecatriene-8,10-diyn-1-ol,|all-trans-1-Hydroxy-tetradecatrien-(4.6.12)-diin-(8.10)|all-trans-Tetradeca-4,6,12-trien-8,10-diin-1-ol|Tetradeca-4,6,12-trien-8,10-diin-1-ol|tetradeca-4,6,12-trien-8,10-diyn-1-ol|Tetradeca-4t,6t,12t-trien-8,10-diin-1-ol|tetradeca-4t,6t,12t-triene-8,10-diyn-1-ol
tetradec-6t-ene-8,10,12-triyn-3-ol|Tetradecatriin-(8.10.12)-en-(6)-ol-(3)|Tetradecen-(6)-triin-(8.10.12)-ol-(3)|trans-Tetradecen-(8)-triin-(2.4.6)-ol-(12)
Silane, (6-ethoxy-3,4-dihydro-2H-pyran-5-yl)trimethyl- (9CI)
C10H20O2Si (200.12325000000004)
(2R)-2-cyclopropyl-2-[[(1R)-1-phenylethyl]amino]acetonitrile
Pyrido[1,2-a]benzimidazole, 1,2,3,4-tetrahydro-3,3-dimethyl- (9CI)
N,N-dimethylpiperazine-1,4-dicarboxamide
C8H16N4O2 (200.12731960000002)
(1E,3Z)-1-methoxy-2-methyl-3-[(trimethylsilyl)oxy]-penta-1,3-diene
C10H20O2Si (200.12325000000004)
1H-Benzimidazole,2-(1-methylethyl)-1-(2-propenyl)-(9CI)
Benzenamine, 4-(2,5-dimethyl-1H-pyrrol-1-yl)-3-methyl- (9CI)
C-(6,7,8,9-TETRAHYDRO-5 H-CARBAZOL-3-YL)-METHYLAMINE
Ethyl 4-carbamimidoylpiperazine-1-carboxylate
C8H16N4O2 (200.12731960000002)
3-Trimethylsilylpropargyl aldehyde diethyl acetal
C10H20O2Si (200.12325000000004)
[(Z)-(1,3-dihydroxy-2,2,5,5-tetramethylimidazolidin-4-ylidene)methyl]diazene
C8H16N4O2 (200.12731960000002)
Pyrido[1,2-a]benzimidazole, 1,2,3,4-tetrahydro-4,9-dimethyl- (9CI)
Cyclohexanecarbothioicacid, S-(1,1-dimethylethyl) ester
2-Ethyl-1-(2-methyl-2-propen-1-yl)-1H-benzimidazole
Thiourea, N-cyclopentyl-N-(1,1-dimethylethyl)- (9CI)
2-(dimethoxymethylsilyl)-bicyclo[2,2,1]heptanes
C10H20O2Si (200.12325000000004)
Pyrido[1,2-a]benzimidazole, 1,2,3,4-tetrahydro-2,2-dimethyl- (9CI)
1H-Benzimidazole,5,6-dimethyl-1-(2-methyl-2-propenyl)-(9CI)
(t-Butyldimethylsilyloxy)cyclopropanecarbaldehyde
C10H20O2Si (200.12325000000004)
2,8-Dimethyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole
LevoMedetoMidine
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics
2,5-Dimethyl-1,2,3,4-tetrahydropyrimido(3,4-a)indole
Trimethylsilyl cyclohexanecarboxylate
C10H20O2Si (200.12325000000004)
PYRIMIDO(3,4-a)INDOLE, 1,2,3,4-TETRAHYDRO-5,7-DIMETHYL-
Methyl ecgonine
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics
4-(1-methyl-2-pyrrolidinyl)-3-oxobutanoate methyl ester
6-methyl-2,3,4,5-tetrahydro-1H-azepino[4,5-b]indole
2-Heptenoic acid,trimethylsilyl ester
C10H20O2Si (200.12325000000004)
Cyclopentylacetic acid trimethylsilyl ester
C10H20O2Si (200.12325000000004)
tetrahydrozoline
R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AB - Sympathomimetics, combinations excl. corticosteroids R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AA - Sympathomimetics, plain S - Sensory organs > S01 - Ophthalmologicals > S01G - Decongestants and antiallergics > S01GA - Sympathomimetics used as decongestants D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D019999 - Pharmaceutical Solutions > D009883 - Ophthalmic Solutions D019141 - Respiratory System Agents > D014663 - Nasal Decongestants D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents Tetrahydrozoline (Tetryzoline), a derivative of imidazoline, is an α-adrenergic agonist that causes vasoconstriction. Tetrahydrozoline is widely used for the research of nasal congestion and conjunctival congestion[1][2].
Dexmedetomidine
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives D002491 - Central Nervous System Agents > D000700 - Analgesics Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Dexmedetomidine ((+)-Medetomidine) is a potent, selective and orally active agonist of α2-adrenoceptor, with a Ki of 1.08 nM. Dexmedetomidine shows 1620-fold selectivity against α1-adrenoceptor. Dexmedetomidine exhibits anxiolysis, sedation, and modest analgesia effects[1][2][3].
N-octanoylglycinate
An N-acylglycinate resulting from the deprotonation of the carboxy group of N-octanoylglycine. The conjugate base of N-octanoylglycine; major species at pH 7.3.
Ecgoninium Methyl Ester(1+)
The conjugate acid of ecgonine methyl ester arising from protonation of the tertiary amino group; major species at pH 7.3.